- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
CCI approves acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures
![CCI approves acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures CCI approves acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures](https://medicaldialogues.in/h-upload/2022/04/08/750x450_173873-acquisition.webp)
Deals beyond certain thresholds require approval from CCI, which keeps a tab on anti-competitive practices in the market place.
New Delhi: The Competition Commission of India on Friday approved the proposed deal involving Sekhmet Pharmaventures and Optimus Drugs Pvt Ltd.
Commission approves acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures & ODPL's acquisition of shareholding in Optimus Pharma & Optimus Life Science pic.twitter.com/h9nOuI0nAb
— CCI (@CCI_India) August 12, 2022
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751